Calvert Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-788,990
Closed -$24.3M 442
2016
Q4
$24.3M Sell
788,990
-57,565
-7% -$1.76M 0.91% 10
2016
Q3
$27.2M Sell
846,555
-5,302
-0.6% -$177K 1% 9
2016
Q2
$28.5M Sell
851,857
-267,004
-24% -$8.52M 1.14% 7
2016
Q1
$31.5M Buy
1,118,861
+6,516
+0.6% +$186K 1.39% 12
2015
Q4
$34.1M Buy
1,112,345
+416,156
+60% +$13.1M 1.55% 7
2015
Q3
$20.7M Buy
696,189
+3,954
+0.6% +$127K 1.03% 30
2015
Q2
$22M Sell
692,235
-62,570
-8% -$2.04M 0.97% 30
2015
Q1
$24.9M Sell
754,805
-72,846
-9% -$2.32M 1.61% 6
2014
Q4
$24.5M Buy
827,651
+193,700
+31% +$5.55M 1.67% 3
2014
Q3
$17.8M Buy
633,951
+215,375
+51% +$6.04M 1.32% 9
2014
Q2
$11.8M Sell
418,576
-25,469
-6% -$726K 0.79% 35
2014
Q1
$13.5M Buy
444,045
+46,308
+12% +$1.38M 0.96% 28
2013
Q4
$11.6M Buy
397,737
+20,774
+6% +$605K 0.84% 38
2013
Q3
$10.3M Buy
376,963
+128,811
+52% +$3.5M 1.28% 7
2013
Q2
$6.59M Buy
+248,152
New +$6.86M 0.9% 36

Other funds holding PFE

Calvert Investment Management's PFE Position: Q1 2017 in Review

Calvert Investment Management sold out of Pfizer (PFE) in Q1 2017, closing a stake of 788,990 shares — an estimated $24.3M sold.

Calvert Investment Management first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $34.1M in Q4 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Calvert Investment Management reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 788,990 Pfizer shares in Q1 2017, an estimated $24.3M.
  • Calvert Investment Management first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's Pfizer position peaked at $34.1M in Q4 2015.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.